An increasing amount of data supports an inverse association between statin use and
cancer risk. The findings for prostate cancer, particularly advanced disease, are the most …

The exact association between statin medication use and prostate cancer, and whether this
association is causal in nature, remains unclear. Recent evidence, however, is encouraging …

Statins are cholesterol-lowering drugs that are widely used to prevent and treat
atherosclerotic cardiovascular disease. Recent research from both in vitro and in vivo …

Statins have been suggested to prevent prostate cancer. Our aim was to examine statin use
in relation to both total prostate cancer and the more clinically important advanced prostate …

Background Men using cholesterol-lowering statin medications have been found to have
lower risks of both advanced and fatal prostate cancer in multiple registry-based studies and …

Background: Statins have known anticarcinogenic effects; evidence for long-term statin use
as effective chemoprevention for prostate cancer is inconsistent. Methods: We conducted a …

The field of the potential applications of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase inhibitors (statins) beyond their unambiguous cardiovascular beneficial effects is …

Background Emerging evidence suggests that statins may decrease the risk of cancers.
However, available evidence on prostate cancer (PCa) is conflicting. We therefore examined …

Background: Statins are commonly used cholesterol-lowering drugs that have proapoptotic
and antimetastatic activities that could affect cancer risk or progression. Results from …

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, known as statins, are
commonly prescribed for the treatment of hypercholesterolemia and cardiovascular disease …